Timing of Adjunctive Therapy in the Treatment of Depression: A Chart Review

Abstract Introduction: The objective of this study was to examine the evolution of antidepressant switch and adjunctive therapy. Methods: This chart review was conducted at 6 primary psychiatric clinics or hospitals, in Tokyo, Japan. A chart review of longitudinal prescriptions was conducted regarding 633 outpatients with major depressive disorder for up to 2 years after their first visit. Patients who had already received antidepressants prior to the visit were excluded. Results: 22.6% (N=143) of the patients completed or continued the outpatient treatment over the 2 years while 27 (4.3%), 23 (3.6%), and 439 (69.4%) patients discontinued it due to hospitalization, referral to another clinic, and loss to follow-up, respectively. A total of 597 episodes of antidepressant treatment were identified. Among them, 482 episodes (80.7%) were associated with the suggested dose ranges while antidepressant drugs were under-dosed in 19.3% (N=115) of the episodes. 50 patients (7.9%) received adjunctive therapy; it was employed after a median of only one antidepressant had been tried. Conclusion: Psychiatrists may be hasty in prescribing an adjunctive therapy in the treatment of depression.

[1]  Maudsley Nhs Trust,et al.  The Maudsley Prescribing Guidelines in Psychiatry , 2015 .

[2]  H. Meltzer,et al.  Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis , 2013, Psychological Medicine.

[3]  K. Andersson Sundell,et al.  Factors associated with switching and combination use of antidepressants in young Swedish adults , 2013, International journal of clinical practice.

[4]  A. Malhotra,et al.  Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. , 2013, The international journal of neuropsychopharmacology.

[5]  S. Stroup,et al.  Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. , 2013, Schizophrenia bulletin.

[6]  A. Graff-Guerrero,et al.  Dopamine D2 Receptor Occupancy and Clinical Effects: A Systematic Review and Pooled Analysis , 2011, Journal of clinical psychopharmacology.

[7]  D. Poyares,et al.  New guidelines for diagnosis and treatment of insomnia. , 2010, Arquivos de neuro-psiquiatria.

[8]  C Michael Stein,et al.  Atypical antipsychotic drugs and the risk of sudden cardiac death. , 2009, The New England journal of medicine.

[9]  S. Patten,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. , 2009, Journal of affective disorders.

[10]  S. Patten,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. , 2009, Journal of affective disorders.

[11]  B. Mulsant,et al.  Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan. , 2009, Journal of anxiety disorders.

[12]  B. Mulsant,et al.  Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[13]  N. Montanaro,et al.  Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression , 2004, Psychopharmacology.